Medartis Holding AG (MED) - Total Assets
Based on the latest financial reports, Medartis Holding AG (MED) holds total assets worth CHF559.92 Million CHF (≈ $707.89 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore MED operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Medartis Holding AG - Total Assets Trend (2014–2025)
This chart illustrates how Medartis Holding AG's total assets have evolved over time, based on quarterly financial data. See MED book value for net asset value and shareholders' equity analysis.
Medartis Holding AG - Asset Composition Analysis
Current Asset Composition (December 2025)
Medartis Holding AG's total assets of CHF559.92 Million consist of 34.9% current assets and 65.1% non-current assets.
| Asset Category | Amount (CHF) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CHF0.00 | 5.9% |
| Accounts Receivable | CHF60.91 Million | 10.9% |
| Inventory | CHF98.20 Million | 17.5% |
| Property, Plant & Equipment | CHF0.00 | 0.0% |
| Intangible Assets | CHF76.02 Million | 13.6% |
| Goodwill | CHF165.40 Million | 29.5% |
Asset Composition Trend (2014–2025)
This chart illustrates how Medartis Holding AG's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see MED stock market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Medartis Holding AG's current assets represent 34.9% of total assets in 2025, a decrease from 39.5% in 2014.
- Cash Position: Cash and equivalents constituted 5.9% of total assets in 2025, up from 1.8% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 42.0% of total assets, an increase from 1.0% in 2014.
- Asset Diversification: The largest asset category is goodwill at 29.5% of total assets.
Medartis Holding AG Competitors by Total Assets
Key competitors of Medartis Holding AG based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Edwards Lifesciences Corp
NYSE:EW
|
USA | $13.32 Billion |
|
DexCom Inc
NASDAQ:DXCM
|
USA | $6.63 Billion |
|
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033
|
China | CN¥805.10 Million |
|
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A
SHG:688212
|
China | CN¥1.86 Billion |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317
|
China | CN¥3.71 Billion |
|
Theradiag SA
PA:ALTHE
|
France | €11.55 Million |
|
Corentec Co Ltd
KQ:104540
|
Korea | ₩175.16 Billion |
|
Adherium Ltd
AU:ADR
|
Australia | AU$4.16 Million |
Medartis Holding AG - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.21 | 5.21 | 6.28 |
| Quick Ratio | 1.10 | 3.66 | 4.35 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CHF107.11 Million | CHF214.93 Million | CHF135.45 Million |
Medartis Holding AG - Advanced Valuation Insights
This section examines the relationship between Medartis Holding AG's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.34 |
| Latest Market Cap to Assets Ratio | 1.68 |
| Asset Growth Rate (YoY) | 21.7% |
| Total Assets | CHF559.92 Million |
| Market Capitalization | $939.71 Million USD |
Valuation Analysis
Above Book Valuation: The market values Medartis Holding AG's assets above their book value (1.68x), reflecting positive investor sentiment about the company's future prospects.
Rapid Asset Growth: Medartis Holding AG's assets grew by 21.7% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Medartis Holding AG (2014–2025)
The table below shows the annual total assets of Medartis Holding AG from 2014 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CHF559.92 Million ≈ $707.89 Million |
+21.73% |
| 2024-12-31 | CHF459.96 Million ≈ $581.52 Million |
+31.59% |
| 2023-12-31 | CHF349.53 Million ≈ $441.91 Million |
+6.60% |
| 2022-12-31 | CHF327.89 Million ≈ $414.55 Million |
+9.97% |
| 2021-12-31 | CHF298.18 Million ≈ $376.98 Million |
+5.44% |
| 2020-12-31 | CHF282.79 Million ≈ $357.53 Million |
-1.98% |
| 2019-12-31 | CHF288.51 Million ≈ $364.76 Million |
+12.79% |
| 2018-12-31 | CHF255.80 Million ≈ $323.41 Million |
+96.03% |
| 2017-12-31 | CHF130.49 Million ≈ $164.98 Million |
+13.23% |
| 2016-12-31 | CHF115.25 Million ≈ $145.70 Million |
+11.87% |
| 2015-12-31 | CHF103.02 Million ≈ $130.25 Million |
+5.10% |
| 2014-12-31 | CHF98.02 Million ≈ $123.92 Million |
-- |
About Medartis Holding AG
Medartis Holding AG, a medical device company, engages in the development, manufacturing, and sales of implant solutions worldwide. The company's medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. It provides products for the hand, wrist, forearm, elbow, shoulder, and foot and ankle, a… Read more